Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;99:53-59

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huraux, C.
Right arrow Articles by Levy, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huraux, C.
Right arrow Articles by Levy, J. H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NITROGLYCERIN
Related Collections
Right arrow Chronic ischemic heart disease
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Risk Factors

(Circulation. 1999;99:53-59.)
© 1999 American Heart Association, Inc.


Clinical Investigation and Reports

Superoxide Production, Risk Factors, and Endothelium-Dependent Relaxations in Human Internal Mammary Arteries

Catherine Huraux, MD; Tetsuji Makita, MD; Sabine Kurz, MD; Koji Yamaguchi, MD; Fania Szlam, MMS; Margaret M. Tarpey, MD; Josiah N. Wilcox, PhD; David G. Harrison, MD; Jerrold H. Levy, MD

From the Department of Anesthesiology (C.H., T.M., K.Y., F.S., J.H.L.) and Department of Medicine, Divisions of Cardiology (S.K., D.G.H.) and Hematology and Oncology (J.N.W.), Emory University Hospital, Atlanta, Ga, and Department of Anesthesiology, University of Alabama, Birmingham, Ala (M.M.T.).

Correspondence to Jerrold H. Levy, MD, Department of Anesthesiology, Emory University Hospital, 1364 Clifton Rd NE, Atlanta, GA 30322. E-mail jerrold_levy{at}emory.org

Background—In a variety of disease states, endothelium-dependent vasodilation is abnormal. Reduced nitric oxide (NO) production, increased destruction of NO by superoxide, diminished cellular levels of L-arginine or tetrahydrobiopterin, and alterations in membrane signaling have been implicated. We examined these potential mechanisms in human vessels.

Methods and Results—Relaxations to acetylcholine, the calcium ionophore A23187, and nitroglycerin, as well as superoxide production and NO synthase expression, were examined in vascular segments from patients with identified cardiovascular risk factors. Endothelium-dependent relaxations were also studied after incubation with L-arginine, L-sepiapterin, and liposome-entrapped superoxide dismutase (SOD) and after organoid culture with cis-vaccenic acid. Relaxations to acetylcholine and to a lesser extent the calcium ionophore A23187 were highly variable and correlated with the number of risk factors present among the subjects studied. Treatment of vessels with L-arginine, L-sepiapterin, liposome-entrapped SOD, or cis-vaccenic acid did not augment endothelium-dependent relaxations. Hypercholesterolemia was the only risk factor associated with high levels of superoxide; however, there was no correlation between superoxide production and the response to either endothelium-dependent vasodilator used.

Conclusions—In human internal mammary arteries, depressed endothelium-dependent relaxations could not be attributed to increases in vascular superoxide production, deficiencies in either L-arginine or tetrahydrobiopterin, or reduced membrane fluidity. Variability in signaling mechanisms may contribute to the differences in responses to acetylcholine and the calcium ionophore A23187.


Key Words: arteries • atherosclerosis • endothelium • nitric oxide • risk factors




This article has been cited by other articles:


Home page
Eur Heart JHome page
A. U. Momin, N. Melikian, A. M. Shah, D. J. Grieve, S. B. Wheatcroft, L. John, A. El Gamel, J. B. Desai, T. Nelson, C. Driver, et al.
Leptin is an endothelial-independent vasodilator in humans with coronary artery disease: evidence for tissue specificity of leptin resistance
Eur. Heart J., October 1, 2006; 27(19): 2294 - 2299.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Al-Benna, C. A. Hamilton, J. D. McClure, P. N. Rogers, G. A. Berg, I. Ford, C. Delles, and A. F. Dominiczak
Low-Density Lipoprotein Cholesterol Determines Oxidative Stress and Endothelial Dysfunction in Saphenous Veins From Patients With Coronary Artery Disease
Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 218 - 223.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Ergul, J. S. Johansen, C. Stromhaug, A. K. Harris, J. Hutchinson, A. Tawfik, A. Rahimi, E. Rhim, B. Wells, R. W. Caldwell, et al.
Vascular Dysfunction of Venous Bypass Conduits Is Mediated by Reactive Oxygen Species in Diabetes: Role of Endothelin-1
J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 70 - 77.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. J. Guzik, J. Sadowski, B. Kapelak, A. Jopek, P. Rudzinski, R. Pillai, R. Korbut, and K. M. Channon
Systemic Regulation of Vascular NAD(P)H Oxidase Activity and Nox Isoform Expression in Human Arteries and Veins
Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1614 - 1620.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Hambrecht, V. Adams, S. Erbs, A. Linke, N. Krankel, Y. Shu, Y. Baither, S. Gielen, H. Thiele, J.F. Gummert, et al.
Regular Physical Activity Improves Endothelial Function in Patients With Coronary Artery Disease by Increasing Phosphorylation of Endothelial Nitric Oxide Synthase
Circulation, July 1, 2003; 107(25): 3152 - 3158.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Blau, B. Thony, J. Vasquez-Vivar, and S. Rajagopalan
Possible Impact of Tetrahydrobiopterin and Sepiapterin on Endothelial Dysfunction * In Response:
Arterioscler. Thromb. Vasc. Biol., May 1, 2003; 23(5): 913 - 915.
[Full Text] [PDF]


Home page
Eur Heart J SupplHome page
R. De Caterina and C. Manes
Inflammation in early atherogenesis: impact of ACE inhibition
Eur. Heart J. Suppl., January 1, 2003; 5(suppl_A): A15 - A24.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Vasquez-Vivar, D. Duquaine, J. Whitsett, B. Kalyanaraman, and S. Rajagopalan
Altered Tetrahydrobiopterin Metabolism in Atherosclerosis: Implications for Use of Oxidized Tetrahydrobiopterin Analogues and Thiol Antioxidants
Arterioscler. Thromb. Vasc. Biol., October 1, 2002; 22(10): 1655 - 1661.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
K. Yokoyama, M. Tajima, H. Yoshida, M. Nakayama, G. Tokutome, H. Sakagami, and T. Hosoya
Plasma pteridine concentrations in patients with chronic renal failure
Nephrol. Dial. Transplant., June 1, 2002; 17(6): 1032 - 1036.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Q. N. Diep, M. El Mabrouk, J. S. Cohn, D. Endemann, F. Amiri, A. Virdis, M. F. Neves, and E. L. Schiffrin
Structure, Endothelial Function, Cell Growth, and Inflammation in Blood Vessels of Angiotensin II-Infused Rats: Role of Peroxisome Proliferator-Activated Receptor-{gamma}
Circulation, May 14, 2002; 105(19): 2296 - 2302.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Heitzer, T. Schlinzig, K. Krohn, T. Meinertz, and T. Munzel
Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease
Circulation, November 27, 2001; 104(22): 2673 - 2678.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. Pompilio, G. Rossoni, F. Alamanni, P. Tartara, I. Barajon, C. Rumio, B. Manfredi, and P. Biglioli
Comparison of endothelium-dependent vasoactivity of internal mammary arteries from hypertensive, hypercholesterolemic, and diabetic patients
Ann. Thorac. Surg., October 1, 2001; 72(4): 1290 - 1297.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Barton and B. Glodny
Endothelin receptor blockade and nitric oxide bioactivity: [Cardiovascular Research 2001;49:146-151]
Cardiovasc Res, October 1, 2001; 52(1): 161 - 163.
[Full Text] [PDF]


Home page
HeartHome page
C. BERRY, N. ANDERSON, A. J B KIRK, A. F DOMINICZAK, and J. J V MCMURRAY
Renin angiotensin system inhibition is associated with reduced free radical concentrations in arteries of patients with coronary heart disease
Heart, August 1, 2001; 86(2): 217 - 220.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Y. Chirkov, A. S. Holmes, S. R. Willoughby, S. Stewart, R. D. Wuttke, P. R. Sage, and J. D. Horowitz
Stable angina and acute coronary syndromes are associated with nitric oxide resistance in platelets
J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1851 - 1857.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. A. Hamilton, M. J. Brosnan, M. McIntyre, D. Graham, and A. F. Dominiczak
Superoxide Excess in Hypertension and Aging : A Common Cause of Endothelial Dysfunction
Hypertension, February 1, 2001; 37(2): 529 - 534.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Verma, F. Lovren, A. S Dumont, K. J Mather, A. Maitland, T. M Kieser, W. Kidd, J. H McNeill, D. J Stewart, C. R Triggle, et al.
Endothelin receptor blockade improves endothelial function in human internal mammary arteries
Cardiovasc Res, January 1, 2001; 49(1): 146 - 151.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Verma, F. Lovren, A. S. Dumont, K. J. Mather, A. Maitland, T. M. Kieser, C. R. Triggle, and T. J. Anderson
Tetrahydrobiopterin improves endothelial function in human saphenous veins
J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 668 - 671.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Ruschitzka, U. Moehrlen, T. Quaschning, M. Lachat, G. Noll, S. Shaw, Z. Yang, D. Teupser, T. Subkowski, M. I. Turina, et al.
Tissue Endothelin-Converting Enzyme Activity Correlates With Cardiovascular Risk Factors in Coronary Artery Disease
Circulation, September 5, 2000; 102(10): 1086 - 1092.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. J. Guzik, N. E. J. West, E. Black, D. McDonald, C. Ratnatunga, R. Pillai, and K. M. Channon
Vascular Superoxide Production by NAD(P)H Oxidase : Association With Endothelial Dysfunction and Clinical Risk Factors
Circ. Res., May 12, 2000; 86 (9): e85 - e90.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Berry, C. A. Hamilton, M. J. Brosnan, F. G. Magill, G. A. Berg, J. J. V. McMurray, and A. F. Dominiczak
Investigation Into the Sources of Superoxide in Human Blood Vessels : Angiotensin II Increases Superoxide Production in Human Internal Mammary Arteries
Circulation, May 9, 2000; 101(18): 2206 - 2212.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. L. Schiffrin, J. B. Park, H. D. Intengan, and R. M. Touyz
Correction of Arterial Structure and Endothelial Dysfunction in Human Essential Hypertension by the Angiotensin Receptor Antagonist Losartan
Circulation, April 11, 2000; 101(14): 1653 - 1659.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. J. Guzik, S. Mussa, D. Gastaldi, J. Sadowski, C. Ratnatunga, R. Pillai, and K. M. Channon
Mechanisms of Increased Vascular Superoxide Production in Human Diabetes Mellitus: Role of NAD(P)H Oxidase and Endothelial Nitric Oxide Synthase
Circulation, April 9, 2002; 105(14): 1656 - 1662.
[Abstract] [Full Text] [PDF]